Systems biology and personalized medicine in cancer

Current Pharmacogenomics and Personalized Medicine

Volumn 8, Issue 1, 2010, Pages 64-72

  Mani, K ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cancer; Drug therapy; Networks; Oncogene; Systems biology

Indexed keywords

TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER GROWTH; CELLULAR PARAMETERS; CHEMICAL ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DRUG SENSITIVITY; EPIGENETICS; GENE EXPRESSION; GENE INTERACTION; GENE MAPPING; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; ONCOGENE; PHENOTYPE; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 77950251519     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/1875692111008010064     Document Type: Review

References (54)

1. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409(6822): 860-921.
2. Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270(5235): 467-470
3. Ren B, Robert F, Wyrick JJ, et al. Genome-wide location and function of DNA binding proteins. Science 2000; 290(5500): 2306-2309
4. Greshock J, Naylor TL, Margolin A, et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res 2004; 14(1): 179-187
5. Dong S, Wang E, Hsie L, et al. Flexible use of high-density oligonucleotide arrays for single-nucleotide polymorphism discovery and validation. Genome Res 2001; 11(8): 1418-1424
6. Perez OD, Nolan GP. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol 2002; 20(2): 155-162
7. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100(1): 57-70.
8. Downward J. Cancer biology: signatures guide drug choice. Nature 2006; 439(7074): 274-275
9. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286(5439): 531-537
10. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415(6871): 530-536
11. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446(7137): 758-764
12. Yao J, Weremowicz S, Feng B, et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 2006; 66(8): 4065-4078
13. Gaasenbeek M, Howarth K, Rowan AJ, et al. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res 2006; 66(7): 3471-3479
14. Kloth JN, Oosting J, van Wezel T, et al. Combined arraycomparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. BMC Genomics 2007; 8: 53.
15. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347(25): 1999-2009.
16. Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365(9460): 671-679
17. Lim WK, Lyashenko E, Califano A. Master regulators used as breast cancer metastasis classifier. Pac Symp Biocomput 2009; 504-515
18. Ein-Dor L, Kela I, Getz G, et al. Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 2005; 21(2): 171-178
19. McMurray HR, Sampson ER, Compitello G, et al. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 2008; 453(7198): 1112-1116
20. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genomewide expression profiles. Proc Natl Acad Sci USA 2005; 102(43): 15545-15550
21. Chen J, Bardes EE, Aronow BJ, et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009; 37(Web Server issue): W305-11.
22. Tomlins SA, Mehra R, Rhodes DR, et al. Integrative molecular concept modeling of prostate cancer progression. Nat Genet 2007; 39(1): 41-51.
23. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007; 9(2): 166-180
24. Ewing RM, Chu P, Elisma F, et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 2007; 3: 89.
25. di Bernardo D, Thompson MJ, Gardner TS, et al. Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat Biotechnol 2005; 23(3): 377-383
26. Margolin AA, Nemenman I, Basso K, et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 2006; 7(Suppl 1): S7.
27. Linding R, Jensen LJ, Ostheimer GJ, et al. Systematic discovery of in vivo phosphorylation networks. Cell 2007; 129(7): 1415-1426
28. Bader GD, Betel D, Hogue CW. BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 2003; 31(1): 248-250
29. Hermjakob H, Montecchi-Palazzi L, Lewington C, et al. IntAct: an open source molecular interaction database. Nucleic Acids Res 2004; 32(Database issue): D452-5.
30. Peri S, Navarro JD, Amanchy R, et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 2003; 13(10): 2363-2371
31. Mewes HW, Frishman D, Mayer KF, et al. MIPS: analysis and annotation of proteins from whole genomes in 2005. Nucleic Acids Res 2006; 34(Database issue): D169-72.
32. Rual JF, Venkatesan K, Hao T, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005; 437(7062): 1173-1178
33. Stelzl U, Worm U, Lalowski M, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005; 122(6): 957-968
34. Ge H, Liu Z, Church GM, et al. Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat Genet 2001; 29(4): 482-486
35. Jansen R, Yu H, Greenbaum D, et al. A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science 2003; 302(5644): 449-453
36. Matys V, Fricke E, Geffers R, et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 2003; 31(1): 374-378
37. Zeller KI, Jegga AG, Aronow BJ, et al. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 2003; 4(10): R69.
38. D'Haeseleer P, Liang S, Somogyi R. Genetic network inference: from co-expression clustering to reverse engineering. Bioinformatics 2000; 16(8): 707-726
39. Friedman N, Linial M, Nachman I, et al. Using Bayesian networks to analyze expression data. J Comput Biol 2000; 7(3-4): 601-620
40. Butte AJ, Kohane IS. Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. Pac Symp Biocomput 2000; 418-429
41. Margolin AA, Wang K, Lim WK, et al. Reverse engineering cellular networks. Nat Protoc 2006; 1(2): 662-671
42. Diella F, Gould CM, Chica C, et al. Phospho.ELM: a database of phosphorylation sites - update 2008. Nucleic Acids Res 2008; 36(Database issue): D240-4.
43. Wang K, Banerjee N, Margolin AA, et al. Genome-wide discovery of modulators of transcriptional interactions in human B lymphocytes. Lecture Notes in Computer Science 2006; 3909: 348-362
44. Chuang HY, Lee E, Liu YT, et al. Network-based classification of breast cancer metastasis. Mol Syst Biol 2007; 3: 140.
45. Watkinson J, Wang X, Zheng T, et al. Identification of gene interactions associated with disease from gene expression data using synergy networks. BMC Syst Biol 2008; 2: 10.
46. Farias EF, Marzan C, Mira-y-Lopez R. Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor- dependent mechanism that regulates p85-p110 heterodimerization. Oncogene 2005; 24(9): 1598-1606
47. Esteller M, Guo M, Moreno V, et al. Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. Cancer Res 2002; 62(20): 5902-5905
48. Ergun A, Lawrence CA, Kohanski MA, et al. A network biology approach to prostate cancer. Mol Syst Biol 2007; 3: 82.
49. Mani KM, Lefebvre C, Wang K, et al. A systems biology approach to prediction of oncogenes and molecular perturbation targets in Bcell lymphomas. Mol Syst Biol 2008; 4: 169.
50. Lefebvre C, Lim WK, Basso K, et al. A context-specific network of protein-DNA and protein-protein interactions reveals new regulatory motifs in human B cells. Lect Notes Bioinformatics (LNCS) 2007; 4532: 42-56.
51. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003; 3(1): 11-22.
52. Solit DB, Garraway LA, Pratilas CA, et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature 2006; 439(7074): 358-362
53. Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006; 439(7074): 353-357
54. Brynildsen MP, Collins JJ. Systems biology makes it personal. Mol Cell 2009; 34(2): 137-138